We are live on ! Find out more
VVM

Versant Venture Management Portfolio holdings

AUM $141M
1-Year Est. Return 190.82%
This Fund
S&P 500
This Quarter Est. Return
+12.62%
1 Year Est. Return
+190.82%
3 Year Est. Return
+375.7%
5 Year Est. Return
+81.85%
10 Year Est. Return
+4,735.29%
AUM
$131M
AUM Growth
+$4.25M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
8
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 66.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BOLD
1
DELISTED
Audentes Therapeutics, Inc
BOLD
$50.9M 38.71%
1,806,832
IMDZ
2
DELISTED
Immune Design Corp.
IMDZ
$23.2M 17.69%
2,208,210
AKAO
3
DELISTED
Achaogen Inc
AKAO
$20.6M 15.68%
1,281,152
OCUL icon
4
Ocular Therapeutix
OCUL
$1.83B
$13.8M 10.54%
2,215,384
CLVS
5
DELISTED
Clovis Oncology, Inc.
CLVS
$8.38M 6.38%
101,855
CBAY
6
DELISTED
Cymabay Therapeutics
CBAY
$8.26M 6.29%
1,048,601
VANI icon
7
Vivani Medical
VANI
$113M
$5.39M 4.1%
187,207
OPGN
8
DELISTED
OpGen, Inc
OPGN
$791K 0.6%
26

Similar funds

Versant Venture Management's Q3 2017 Portfolio in Review

As of Q3 2017, Versant Venture Management held 8 positions worth $131M, up 3.3% from $127M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2017: portfolio turnover was 0%. Versant Venture Management opened no new positions and made no exits, leaving the 8-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, up from 60% a quarter earlier.

  • Versant Venture Management's ten largest holdings make up 100% of its $131M portfolio in Q3 2017.
  • Versant Venture Management opened 0 new positions and closed 0 in Q3 2017.
  • Versant Venture Management's portfolio value rose 3.3% quarter-over-quarter to $131M.

Based on Versant Venture Management's 13F filing for Q3 2017, filed 13 Oct 2017.